MARSANA BRUNNER: Open Payments
NPI 1841738796 · BLOUNTSTOWN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 25 payments from 9 companies in 2025. Trend: 2023 $286 · 2024 $371 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 7 | $160 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| Lilly USA, LLC | 3 | $48 |
| Gilead Sciences, Inc. | 2 | $40 |
| IBSA Pharma Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Ohtuvayre, TRELEGY ELLIPTA, MOUNJARO, Tirosint, AIRSUPRA, LEQVIO, Wegovy, Rybelsus.
Industry payments across FL — which companies pay providers there.
